Trial Profile

A Phase 2, Open-Label, Multi-Center, Randomized Trial to Demonstrate the Pharmacokinetics of LCP-Tacro Tablets Once Daily and Prograf Capsules Twice Daily in Adult De Novo Liver Transplant Patients

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Dec 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tacrolimus (Primary)
Indications Liver transplant rejection
Focus Adverse reactions; Pharmacokinetics
Sponsors Veloxis Pharmaceuticals

Most Recent Events

03 Jul 2012 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
03 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
06 Jan 2011 Top-line, long-term safety and efficacy data are positive, according to a LifeCycle Pharma media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com